We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid Tuberculosis Detection Test Endorsed by Experts

By LabMedica International staff writers
Posted on 12 Feb 2013
A diagnostic test for tuberculosis (TB) that can accurately and quickly detect both TB and drug-resistant strains has been authorized by leading experts in the field.

The diagnostic accuracy of the Xpert MTB/RIF test can provide timely advice for clinicians and policymakers in countries where TB is a major public health problem and where drug resistance further complicates efforts to control TB.

Scientists from the Cochrane Infectious Diseases Group, McGill University (Montreal, QC, Canada) and the Foundation for Innovative New Diagnostics (FIND; Geneva, Switzerland), analyzed data from 18 studies involving a total of 7,816 people, with most studies being carried out in low- and middle-income countries. More...
Their analysis showed that when Xpert MTB/RIF test is being used as a replacement for smear microscopy for 1,000 people being screened, of whom 150 have TB, the test picks up 132 of the 150 cases (88%) and falsely diagnoses 17 (2%) with TB.

Where the Xpert test is being used as a replacement for culture-based drug susceptibility testing, it is also able to detect the equivalent of 141 out of 150 cases (94%) of rifampicin resistance. When Xpert is used as a follow-on test, after conventional smear microscopy has already produced a negative result, it picks up 101 out of 150 cases (67%). As smear-negative TB is not picked up by smear microscopy because microscopy cannot detect small numbers of bacteria, Xpert picked up 67% of this group that would have been missed by microscopy.

The authors concluded that when the Xpert assay is used as an initial diagnostic test for TB detection and rifampicin resistance detection in patients suspected of having TB, multi-drug-resistant (MDR)-TB, or human immunodeficiency virus (HIV)-associated TB, it is both sensitive and specific. Xpert may also be valuable as an add-on test following microscopy for patients who have previously been found to be smear-negative. An Xpert result that is positive for rifampicin resistance should be carefully interpreted and take into consideration the risk of MDR-TB in a given patient and the expected prevalence of MDR-TB in a given setting. The Xpert MTB/RIF test is manufactured by Cepheid Inc (Sunnyvale, CA, USA).

Karin Weyer, DSc, Coordinator, Laboratories, Diagnostics and Drug Resistance at the World Health Organization (WHO; Geneva, Switzerland) said, "This Cochrane Review provides high quality evidence that reinforces WHO's endorsement of this test. Recent price reductions have greatly facilitated rollout of this technology with 1.4 million test cartridges and over 200 GeneXpert instruments for the rapid detection of TB and rifampicin resistance will be distributed in 21 countries with a high burden of TB." The review was published on January 31, 2013, in the Cochrane Library.

Related Links:
McGill University
Foundation for Innovative New Diagnostics
Cepheid Inc.


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Serological Pipet Controller
PIPETBOY GENIUS
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.